ZIOPHARM ONCOLOGY INC Contracts & Agreements

142 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Cooperative Research and Development Agreement, dated January 9, 2017, by and among the National Cancer Institute, Ziopharm Oncology, Inc. and Intrexon Corporation
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
DC
2019
Consulting Agreement, dated as of November 14, 2023, between the Registrant and Melinda Lackey
Consulting Agreements
ZIOPHARM ONCOLOGY INC
2024
Separation Agreement, dated as of December 22, 2023, between the Registrant and Kevin S. Boyle, Sr
Separation Agreements
ZIOPHARM ONCOLOGY INC
2024
Consulting Agreement, dated as of December 22, 2023, between the Registrant and Kevin S. Boyle, Sr
Consulting Agreements
ZIOPHARM ONCOLOGY INC
2024
Consulting Agreement, dated as of February 21, 2024, between the Registrant and Ferdinand Groenewald
Consulting Agreements
ZIOPHARM ONCOLOGY INC
2024
Retention Agreement, dated as of August 14, 2023, between the Registrant and Melinda Lackey
Retention Agreements
ZIOPHARM ONCOLOGY INC
2023
Retention Agreement, dated as of August 14, 2023, between the Registrant and Drew Deniger
Retention Agreements
ZIOPHARM ONCOLOGY INC
2023
Underwriting Agreement, dated as of November 29, 2022, by and between Alaunos Therapeutics, Inc. and Cantor Fitzgerald & Co
Underwriting Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2022
Fourth Amendment to the Cooperative Research and Development Agreement, dated June 24, 2022, by and between the National Cancer Institute and the Registrant
Development Agreements
ZIOPHARM ONCOLOGY INC
2022
Equity Distribution Agreement, dated August 12, 2022, by and between Piper Sandler & Co. and the Registrant
Equity Distribution Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2022
Form of Warrant to Purchase Shares of Common Stock issued to SVB and certain of its Affiliates, dated December 28, 2021
Warrant Agreements
ZIOPHARM ONCOLOGY INC
2022
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
ZIOPHARM ONCOLOGY INC
Biotechnology
DE
2022
Employment Agreement, dated April 23, 2019, by and between the Registrant and Jill Buck
Employment Agreements
ZIOPHARM ONCOLOGY INC
2022
Amendment to Employment Agreement, dated November 23, 2020, by and between the Registrant and Jill Buck
Employment Agreements
ZIOPHARM ONCOLOGY INC
2022
Employment Agreement, dated April 23, 2019, by and between the Registrant and Eleanor de Groot
Employment Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2022
Amendment to Employment Agreement, dated November 23, 2020, by and between the Registrant and Eleanor de Groot
Employment Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2022
Employment Agreement, dated September 30, 2020, by and between the Registrant and Raffaele Baffa
Employment Agreements
ZIOPHARM ONCOLOGY INC
2022
Amendment to Employment Agreement, dated November 23, 2020, by and between the Registrant and Raffaele Baffa
Employment Agreements
ZIOPHARM ONCOLOGY INC
2022
Third Amendment to Patent License Agreement, dated as of April 16, 2021, by and between the Registrant and the National Cancer Institute
License Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2022
Fourth Amendment to Patent License Agreement, dated as of May 4, 2021, by and between the Registrant and the National Cancer Institute
License Agreements
ZIOPHARM ONCOLOGY INC
2022
Fifth Amendment to Patent License Agreement, dated as of August 13, 2021, by and between the Registrant and the National Cancer Institute
License Agreements
ZIOPHARM ONCOLOGY INC
2022
Third Amendment to the Cooperative Research and Development Agreement, dated March 15, 2022, by and among the National Cancer Institute and the Registrant
Development Agreements
ZIOPHARM ONCOLOGY INC
2022
First Amendment to the Loan and Security Agreement by and among the Registrant, the lenders party thereto and Silicon Valley Bank, as administrative agent and collateral agent,...
Loan Agreements
ZIOPHARM ONCOLOGY INC
2022
Separation Agreement, dated March 28, 2022, by and between the Registrant and Dr. Raffaele Baffa
Separation Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2022
Form of Warrant to Purchase Shares of Common Stock dated August 6, 2021
Warrant Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2021
Loan and Security Agreement by and among the Registrant, the lenders party thereto and Silicon Valley Bank, as administrative agent and collateral agent, dated August 6, 2021
Loan Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
CA
2021
Employment Agreement by and between ZIOPHARM Oncology, Inc. and Kevin S. Boyle, Sr., dated August 24, 2021
Employment Agreements
ZIOPHARM ONCOLOGY INC
2021
Separation Agreement by and between the Company and Dr. Laurence Cooper, dated April 5, 2021
Separation Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
MA
2021
Consulting Agreement by and between the Company and Dr. Laurence Cooper, entered into on April 5, 2021
Consulting Agreements
ZIOPHARM ONCOLOGY INC
2021
Employment Agreement by and between Ziopharm Oncology, Inc. and Heidi Hagen, dated February 25, 2021
Employment Agreements
ZIOPHARM ONCOLOGY INC
2021
Form of Restricted Stock Agreement Granted Under the ZIOPHARM Oncology, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
ZIOPHARM ONCOLOGY INC
2021
Form of Stock Option Agreement Granted Under the ZIOPHARM Oncology, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
ZIOPHARM ONCOLOGY INC
2021
Amendment to the Employment Agreement by and between the Registrant and Robert Hadfield, dated as of November 23, 2020
Employment Agreements
ZIOPHARM ONCOLOGY INC
2021
Amendment to the Employment Agreement by and between the Registrant and Sath Shukla, dated as of November 23, 2020
Employment Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2021
Form of Retention Bonus Agreement
Bonus & Incentive Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2021
Lease Agreement, dated as of October 15, 2019, by and between the Registrant and The University of Texas System Board of Regents on behalf of The University of Texas M.D. Anderson...
Lease Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
TX
2021
First Amendment, dated as of April 7, 2020, to the Lease Agreement, dated as of October 15, 2019, by and between the Registrant and The University of Texas System Board of Regents...
Lease Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
TX
2021
Second Amendment, dated as of April 7, 2020, to the Lease Agreement, dated as of October 15, 2019, by and between the Registrant and The University of Texas System Board of...
Lease Agreements
ZIOPHARM ONCOLOGY INC
2021
Third Amendment, dated as of December 15, 2020, to the Lease Agreement, dated as of October 15, 2019, by and between the Registrant and The University of Texas System Board of...
Lease Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2021
Lease Agreement dated as of December 15, 2020, by and between the Registrant and The University of Texas System Board of Regents on behalf of The University of Texas M.D. Anderson...
Lease Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
TX
2021
Consulting Agreement by and between Ziopharm Oncology Inc. and Danforth Advisors LLC, effective as of January 21, 2021
Consulting Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
MA
2021
Agreement, by and among ZIOPHARM Oncology, Inc., WaterMill Asset Management Corp. Robert W. Postma, Jamie Vieser, and Holger Weis, dated February 4, 2021
Management Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
DE
2021
Second Amendment to Patent License Agreement, dated as of September 28, 2020, by and between the Registrant and the National Cancer Institute
License Agreements
ZIOPHARM ONCOLOGY INC
2020
Amendment No. 1 to the Exclusive License Agreement by and between the Registrant and PGEN Therapeutics, Inc. (formerly known as Precigen, Inc.), dated October 15, 2020
License Agreements
ZIOPHARM ONCOLOGY INC
2020
Ziopharm Oncology, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
DE
2020
Consulting Agreement by and between the Company and Dr. David Mauney, dated May 26, 2020
Consulting Agreements
ZIOPHARM ONCOLOGY INC
2020
Separation Agreement and Release by and between the Company and Dr. David Mauney, effective May 26, 2020
Separation Agreements
ZIOPHARM ONCOLOGY INC
2020
Warrant to Purchase Common Stock issued to The University of Texas M. D. Anderson Cancer Center
Warrant Agreements
ZIOPHARM ONCOLOGY INC
2020
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act Of 1934, as amended
ZIOPHARM ONCOLOGY INC
Biotechnology
DE
2020
Fifth Amendment to Research and Development Agreement, dated October 22, 2019 by and among the Registrant and The University of Texas MD Anderson Cancer Center
Development Agreements
ZIOPHARM ONCOLOGY INC
2020
2019 Research and Development Agreement, dated October 22, 2019, by and between the Registrant and The University of Texas MD Anderson Cancer Center
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
TX
2020
Amendment to Patent License Agreement, dated as of January 8, 2020 , by and between the Company and the National Cancer Institute
License Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2020
Underwriting Agreement by and between Ziopharm Oncology, Inc. and Jefferies LLC, dated February 5, 2020
Underwriting Agreements
ZIOPHARM ONCOLOGY INC
2020
Fourth Amendment to Research and Development Agreement, dated September 19, 2019 by and between the Registrant, The University of Texas MD Anderson Cancer Center and Precigen, Inc
Development Agreements
ZIOPHARM ONCOLOGY INC
2019
Amendment #1 to the Cooperative Research and Development Agreement, dated March 23, 2018, by and among the National Cancer Institute, Ziopharm Oncology, Inc., Intrexon Corporation...
Development Agreements
ZIOPHARM ONCOLOGY INC
2019
Amendment #2 to the Cooperative Research and Development Agreement, dated February 1, 2019, by and among the National Cancer Institute, Ziopharm Oncology, Inc. and Precigen, Inc
Development Agreements
ZIOPHARM ONCOLOGY INC
2019
Form of New Warrant to Purchase Common Stock (September 2019)
Warrant Agreements
ZIOPHARM ONCOLOGY INC
2019
Form of Securities Issuance Agreement (September 2019)
ZIOPHARM ONCOLOGY INC
Biotechnology
MA
2019
Form of Registration Rights Agreement (September 2019)
Registration Rights Agreements
ZIOPHARM ONCOLOGY INC
2019
Patent License Agreement, dated as of May 28, 2019, by and between the Company and the National Cancer Institute
License Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Form of New Warrant to Purchase Common Stock
Warrant Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
MA
2019
Form of Securities Issuance Agreement
ZIOPHARM ONCOLOGY INC
2019
Form of Registration Rights Agreement
Registration Rights Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
MA
2019
Placement Agency Agreement, dated July 26, 2019, by and among Ziopharm Oncology, Inc. and Raymond James & Associates, Inc
Agency Agreements
ZIOPHARM ONCOLOGY INC
2019
Employment Agreement by and between Ziopharm Oncology, Inc. and Sath Shukla
Employment Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Inducement Award Agreement by and between Ziopharm Oncology, Inc. and Sath Shukla
ZIOPHARM ONCOLOGY INC
2019
Employment Agreement, dated as of April 23, 2019, by and between the Company and David Mauney, M.D
Employment Agreements
ZIOPHARM ONCOLOGY INC
2019
Employment Agreement, dated as of April 23, 2019, by and between the Company and Robert Hadfield
Employment Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Amendment #1 to the Research and Development Agreement by and among the Registrant, Intrexon Corporation and The University of Texas M.D. Anderson Cancer Center dated as of August...
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Amendment #2 to the Research and Development Agreement by and among the Registrant, Intrexon Corporation and The University of Texas M.D. Anderson Cancer Center dated as of...
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Amendment #3 to the Research and Development Agreement by and among the Registrant, Intrexon Corporation and The University of Texas M.D. Anderson Cancer Center dated as of...
Development Agreements
ZIOPHARM ONCOLOGY INC
2019
Form of Warrant to Purchase Common Stock
Warrant Agreements
ZIOPHARM ONCOLOGY INC
2018
Form of Securities Purchase Agreement
Purchase Agreements
ZIOPHARM ONCOLOGY INC
2018
Form of Registration Rights Agreement
Registration Rights Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
MA
2018
Placement Agency Agreement, dated November 11, 2018, by and among Ziopharm Oncology, Inc. and Raymond James & Associates, Inc
Agency Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2018
Exclusive License Agreement by and between the registrant, Precigen, Inc. and Intrexon Corporation, dated October 5, 2018
License Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2018
Ziopharm Oncology, Inc. 2012 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
DE
2018
Separation Agreement by and between ZIOPHARM Oncology, Inc. and Caesar J. Belbel dated as of February 15, 2018
Separation Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
MA
2018
Offer Letter by and between ZIOPHARM Oncology, Inc. and David M. Mauney, M.D
ZIOPHARM ONCOLOGY INC
2017
Severance Agreement by and between ZIOPHARM Oncology, Inc. and David M. Mauney, M.D
Severance Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
MA
2017
Inducement Award Agreement by and between ZIOPHARM Oncology, Inc. and David M. Mauney, M.D
ZIOPHARM ONCOLOGY INC
2017
ZIOPHARM Oncology, Inc. 9,708,738 Shares of Common Stock Underwriting Agreement
Underwriting Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2017
EXCLUSIVE CHANNEL PARTNER AGREEMENT
ZIOPHARM ONCOLOGY INC
2017
THIRD AMENDMENT TO EXCLUSIVE CHANNEL PARTNERAGREEMENT
ZIOPHARM ONCOLOGY INC
Biotechnology
2016
AMENDMENT TO EXCLUSIVE CHANNEL COLLABORATIONAGREEMENT
ZIOPHARM ONCOLOGY INC
Biotechnology
2016
SECURITIES ISSUANCE AGREEMENT
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2016
EXCLUSIVE CHANNEL COLLABORATION AGREEMENT
Collaboration Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2015
RESEARCH AND DEVELOPMENT AGREEMENT
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
TX
2015
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
ZIOPHARM ONCOLOGY INC
2015
EMPLOYMENT AGREEMENT
Employment Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2015
Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A...
ZIOPHARM ONCOLOGY INC
Biotechnology
2015
SECOND AMENDMENT TO EXCLUSIVE CHANNEL PARTNERAGREEMENT
ZIOPHARM ONCOLOGY INC
Biotechnology
2015
ZIOPHARM Oncology, Inc. 10,000,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2015
LICENSE AGREEMENT
License Agreements
ZIOPHARM ONCOLOGY INC
2015
SECURITIES ISSUANCE AGREEMENT
ZIOPHARM ONCOLOGY INC
2015
SECURITIES ISSUANCE AGREEMENT
ZIOPHARM ONCOLOGY INC
2015
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
TN
2015
ZIOPHARM ONCOLOGY, INC. 2012 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 7, 2012 APPROVED BY THE STOCKHOLDERS: JUNE 20, 2012 AMENDED BY THE BOARD OF DIRECTORS:...
Bonus & Incentive Agreements
ZIOPHARM ONCOLOGY INC
2014
ZIOPHARM ONCOLOGY, INC. 2012 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 7, 2012 APPROVED BY THE STOCKHOLDERS:JUNE 20, 2012 AMENDED BY THE BOARD OFDIRECTORS:...
Bonus & Incentive Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
DE
2014
AMENDED AND RESTATED SEVERANCE AGREEMENT
Severance Agreements
ZIOPHARM ONCOLOGY INC
2014
AMENDMENT AND EXTENSION TO EMPLOYMENT AGREEMENT
Employment Agreements
ZIOPHARM ONCOLOGY INC
2014
AMENDMENT TO EMPLOYMENTAGREEMENT
ZIOPHARM ONCOLOGY INC
Biotechnology
MA
2014
ZIOPHARMOncology, Inc. 14,300,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreements
ZIOPHARM ONCOLOGY INC
2013
EXTENSION OF EMPLOYMENT AGREEMENT
Employment Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2013
ZIOPHARMOncology, Inc. 2012Equity Incentive Plan Adoptedby the Board of Directors: March 7, 2012 Approvedby the Stockholders: June 20, 2012
Bonus & Incentive Agreements
ZIOPHARM ONCOLOGY INC
2012
ZIOPHARMOncology, Inc. 2012Equity Incentive Plan Formof Restricted Stock Agreement
Bonus & Incentive Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2012
ZIOPHARMOncology, Inc. 2012 Equity Incentive Plan Form of Option Agreement (Incentive Stock Option or Nonstatutory Stock Option)
Bonus & Incentive Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2012
EMPLOYMENTAGREEMENT
ZIOPHARM ONCOLOGY INC
Biotechnology
2012
FIRST AMENDMENT TO EXCLUSIVE CHANNELPARTNER AGREEMENT
ZIOPHARM ONCOLOGY INC
2012
ZIOPHARM ONCOLOGY, INC. AmendmentNo. 1 to EmploymentAgreement
ZIOPHARM ONCOLOGY INC
2012
ZIOPHARM Oncology, Inc. 9,650,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2012
EMPLOYMENT AGREEMENT
Employment Agreements
ZIOPHARM ONCOLOGY INC
2011
EMPLOYMENT AGREEMENT
Employment Agreements
ZIOPHARM ONCOLOGY INC
2011
EMPLOYMENT AGREEMENT
Employment Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2011
ZIOPHARM ONCOLOGY, INC. AMENDED AND RESTATED 2003 STOCK OPTION PLAN (Amended and restated as of September 1, 2010)
Stock Agreements
ZIOPHARM ONCOLOGY INC
2011
Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2011
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2011
9,600,000Shares ZIOPHARMONCOLOGY, INC. CommonStock ($0.001par value per Share) UNDERWRITINGAGREEMENT
Share Agreements
ZIOPHARM ONCOLOGY INC
2011
AMENDMENTTO STOCKPURCHASE AGREEMENT
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2011
ExclusiveChannel Partner Agreement
ZIOPHARM ONCOLOGY INC
2011
STOCKPURCHASE AGREEMENT
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2011
EXTENSIONOF EMPLOYMENT AGREEMENT
Employment Agreements
ZIOPHARM ONCOLOGY INC
2010
7,000,000Shares ZIOPHARMONCOLOGY, INC. CommonStock ($0.001par value per Share) UNDERWRITINGAGREEMENT
Share Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2010
15,484,000Shares Warrantsto Purchase 7,742,000Shares ZIOPHARMOncology, Inc. CommonStock ($0.001par value) UNDERWRITINGAGREEMENT
Purchase Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2009
Formof Underwriters Warrant ZIOPHARMONCOLOGY, INC. WARRANTTO PURCHASE COMMON STOCK
Warrant Agreements
ZIOPHARM ONCOLOGY INC
2009
ZIOPHARMONCOLOGY, INC. WARRANTTO PURCHASE COMMON STOCK
Stock Agreements
ZIOPHARM ONCOLOGY INC
2009
SECURITIESPURCHASE AGREEMENT
ZIOPHARM ONCOLOGY INC
2009
REGISTRATIONRIGHTS AGREEMENT
Registration Rights Agreements
ZIOPHARM ONCOLOGY INC
2009
EMPLOYMENT AGREEMENT
Employment Agreements
ZIOPHARM ONCOLOGY INC
2008
Form of Restricted Stock Agreement ZIOPHARM Oncology, Inc. Restricted Stock Agreement
Stock Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2007
EMPLOYMENT AGREEMENT EXTENSION
Employment Agreements
ZIOPHARM ONCOLOGY INC
2007
ZIOPHARM ONCOLOGY, INC. WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
ZIOPHARM ONCOLOGY INC
2007
ZIOPHARM ONCOLOGY, INC. WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
ZIOPHARM ONCOLOGY INC
2007
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
ZIOPHARM ONCOLOGY INC
2007
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
ZIOPHARM ONCOLOGY INC
2007
EMPLOYMENT AGREEMENT EXTENSION
Employment Agreements
ZIOPHARM ONCOLOGY INC
2006
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANT
Warrant Agreements
ZIOPHARM ONCOLOGY INC
2006
Form of Placement Agent Warrant
Warrant Agreements
ZIOPHARM ONCOLOGY INC
2006
SUBSCRIPTION AGREEMENT
Subscription Agreements
ZIOPHARM ONCOLOGY INC
2006
ZIOPHARM Oncology, Inc. Amendment No. 1 to 2003 Stock Option Plan
Stock Agreements
ZIOPHARM ONCOLOGY INC
2006
Agreement and Plan of Merger dated August 3, 2005
Merger Agreements
ZIOPHARM ONCOLOGY INC
2005
Employment Agreement, dated as of January 21, 2024, by and between the Registrant and Dale Curtis Hogue
ZIOPHARM ONCOLOGY INC
2024